Androgen interaction with the oestrogen receptor in human tissues.
D015113:Androstane-3,17-diol / Q000494:pharmacology*; D000732:Androstanols / Q000494:pharmacology*; D015114:Androstenediol / Q000494:pharmacology*; D000734:Androstenediols / Q000494:pharmacology*; D001667:Binding, Competitive / Q000187:drug effects; D001943:Breast Neoplasms / Q000378:metabolism; D002460:Cell Line; D004717:Endometrium / Q000378:metabolism*; D004958:Estradiol / Q000378:metabolism; D005260:Female; D006801:Humans; D007700:Kinetics; D011960:Receptors, Estrogen / Q000187:drug effects* / Q000378:metabolism; D011980:Receptors, Progesterone / Q000187:drug effects; D013937:Thymidine Kinase / Q000378:metabolism
D000732:Androstanols; D000734:Androstenediols; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D015113:Androstane-3,17-diol; D004958:Estradiol; D015114:Androstenediol; D013937:Thymidine Kinase